Current Status of the Evaluation and Management of Lupus Patients and Future Prospects
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Status of the Evaluation and Management of Lupus Patients and Future Prospects
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-28
DOI
10.3389/fmed.2021.682544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis
- (2020) Rachel Knevel et al. Science Translational Medicine
- Mapping systemic lupus erythematosus heterogeneity at the single-cell level
- (2020) Djamel Nehar-Belaid et al. NATURE IMMUNOLOGY
- Genetic risk scores in inflammatory arthritis: a new era?
- (2020) Matthew A. Brown et al. Nature Reviews Rheumatology
- Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls
- (2020) Irene E M Bultink et al. RHEUMATOLOGY
- Author Correction: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
- (2020) Samantha Stanley et al. Nature Communications
- Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis
- (2020) Andrea Fava et al. JCI Insight
- Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus
- (2020) Michelle D. Catalina et al. JCI Insight
- Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries
- (2020) Katherine A. Owen et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Transforming clinical trials in rheumatology: towards patient-centric precision medicine
- (2020) Costantino Pitzalis et al. Nature Reviews Rheumatology
- New insights into the role of antinuclear antibodies in systemic lupus erythematosus
- (2020) David S. Pisetsky et al. Nature Reviews Rheumatology
- Urinary biomarkers in lupus nephritis: are we there yet?
- (2020) Chi Chiu Mok et al. Arthritis & Rheumatology
- Response to: ‘Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’’ by Ronnelid et al
- (2020) Sindhu R Johnson et al. ANNALS OF THE RHEUMATIC DISEASES
- A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patients
- (2020) Patrick Coit et al. JCI Insight
- Current challenges in the development of new treatments for lupus
- (2019) Maria Dall'Era et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus
- (2019) Michelle Petri et al. BMC Medical Genomics
- Fatigue Measurements in Systemic Lupus Erythematosus
- (2019) Ariane Barbacki et al. JOURNAL OF RHEUMATOLOGY
- All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971–2013)
- (2019) Konstantinos Tselios et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways
- (2019) Evan Der et al. NATURE IMMUNOLOGY
- Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date
- (2019) Renaud Felten et al. Drug Design Development and Therapy
- Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies
- (2019) Andreas Schwarting et al. ANNALS OF THE RHEUMATIC DISEASES
- The immune cell landscape in kidneys of patients with lupus nephritis
- (2019) Arnon Arazi et al. NATURE IMMUNOLOGY
- Machine learning approaches to predict lupus disease activity from gene expression data
- (2019) Brian Kegerreis et al. Scientific Reports
- Role of ANA testing in the classification of patients with systemic lupus erythematosus
- (2019) David S Pisetsky et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
- (2019) Martin Aringer et al. Arthritis & Rheumatology
- Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification
- (2019) Daniel Toro-Domínguez et al. Scientific Reports
- High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
- (2019) Sarah Reid et al. ANNALS OF THE RHEUMATIC DISEASES
- Limited role of specificity of ANA for SLE classification. Response to: ‘European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view’ by Infantino et al
- (2019) Martin Aringer et al. ANNALS OF THE RHEUMATIC DISEASES
- The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus
- (2019) Michelle D. Catalina et al. JOURNAL OF AUTOIMMUNITY
- Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis
- (2019) Deepak A. Rao et al. Nature Reviews Nephrology
- Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
- (2019) Kathryn M. Kingsmore et al. Nature Reviews Rheumatology
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
- (2018) Juliana Imgenberg-Kreuz et al. ANNALS OF THE RHEUMATIC DISEASES
- Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
- (2018) Ingeborg M. Bajema et al. KIDNEY INTERNATIONAL
- Individuals living with lupus: findings from the LUPUS UK Members Survey 2014
- (2018) C Morgan et al. LUPUS
- Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms
- (2018) Joan E. Wither et al. PLoS One
- The SLE-key test serological signature: new insights into the course of lupus
- (2018) Chaim Putterman et al. RHEUMATOLOGY
- Development and Validation of a Novel Evidence-Based Lupus Multivariable Outcome Score for Clinical Trials
- (2018) Michal Abrahamowicz et al. Arthritis & Rheumatology
- Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort
- (2018) Michelle Petri et al. Arthritis & Rheumatology
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria
- (2018) Sindhu R. Johnson et al. JOURNAL OF RHEUMATOLOGY
- Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014)
- (2017) April M Jorge et al. RHEUMATOLOGY
- Transancestral mapping and genetic load in systemic lupus erythematosus
- (2017) Carl D. Langefeld et al. Nature Communications
- Epigenetic Variability in Systemic Lupus Erythematosus: What We Learned from Genome-Wide DNA Methylation Studies
- (2017) Maria Teruel et al. Current Rheumatology Reports
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Remission in systemic lupus erythematosus: durable remission is rare
- (2016) Theresa R Wilhelm et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
- (2016) L Andreoli et al. ANNALS OF THE RHEUMATIC DISEASES
- IFI44Lpromoter methylation as a blood biomarker for systemic lupus erythematosus
- (2016) Ming Zhao et al. ANNALS OF THE RHEUMATIC DISEASES
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
- (2016) Romain Banchereau et al. CELL
- Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens
- (2016) Yohann Nédélec et al. CELL
- Cause and consequences of the activated type I interferon system in SLE
- (2016) Maija-Leena Eloranta et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis
- (2016) A C Grammer et al. LUPUS
- New insights into the immunopathogenesis of systemic lupus erythematosus
- (2016) George C. Tsokos et al. Nature Reviews Rheumatology
- Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares
- (2016) Patrick Coit et al. Arthritis & Rheumatology
- Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis
- (2016) Maria G. Tektonidou et al. Arthritis & Rheumatology
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
- (2015) Kate Franklyn et al. ANNALS OF THE RHEUMATIC DISEASES
- The frequency and outcome of lupus nephritis: results from an international inception cohort study
- (2015) John G. Hanly et al. RHEUMATOLOGY
- Distinctions Between Diagnostic and Classification Criteria?
- (2015) Rohit Aggarwal et al. ARTHRITIS CARE & RESEARCH
- Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research
- (2015) Jamal Mikdashi et al. ARTHRITIS RESEARCH & THERAPY
- Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
- (2014) Ian N Bruce et al. ANNALS OF THE RHEUMATIC DISEASES
- Lupus Nephritis Susceptibility Loci in Women with Systemic Lupus Erythematosus
- (2014) S. A. Chung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
- (2013) Vibeke Strand et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model
- (2013) K Beusterien et al. LUPUS
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- A Systematic Review of Communication Quality Improvement Interventions for Patients with Advanced and Serious Illness
- (2012) Oluwakemi A. Fawole et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000s
- (2012) Anselm Mak et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
- (2011) J. T. Dudley et al. Science Translational Medicine
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
- (2011) Hans-Peter Tony et al. ARTHRITIS RESEARCH & THERAPY
- MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1
- (2010) W. Pan et al. JOURNAL OF IMMUNOLOGY
- Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome
- (2010) A. J. STEIMAN et al. JOURNAL OF RHEUMATOLOGY
- Clinical trials in lupus: what have we learned so far?
- (2010) I. N. Bruce et al. RHEUMATOLOGY
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Novel evidence-based systemic lupus erythematosus responder index
- (2009) Richard A. Furie et al. ARTHRITIS AND RHEUMATISM
- MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
- (2009) Yuanjia Tang et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Lack of association between the interferon- signature and longitudinal changes in disease activity in systemic lupus erythematosus
- (2008) C Landolt-Marticorena et al. ANNALS OF THE RHEUMATIC DISEASES
- Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression
- (2008) Charles L. Raison et al. BIOLOGICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started